Maternal, fetal, and neonatal outcomes among different types of hypertensive disorders associating pregnancy needing intensive care management

References

• Cunningham FG, Leveno KJ, Bloom SL, et al. Hypertensive disorders. In: Cunningham FG, Williams JW, editors. William’s obstetrics. 24th ed. New York (NY): McGraw-Hill; 2014. p. 728–797. Chapter 40.
   Google Scholar
• Sibai BM, Cunningham FG. Prevention of preeclampsia and eclampsia. In: Lindheimer MD, Roberts JM, Cunningham FG, editors. Chesley’s hypertensive disorders of pregnancy. 3rd ed. New York (NY): Elsevier; 2009. p. 215.
   Google Scholar
• Maged AM, ElNassery N, Fouad M, et al. Third-trimester uterine artery Doppler measurement and maternal postpartum outcome among patients with severe pre-eclampsia. Int J Gynecol Obstet. 2015;131(1):49–53.
   PubMed Web of Science ®Google Scholar
• Maged AM, Aid G, Bassiouny N, et al. Association of biochemical markers with the severity of pre-eclampsia. Int J Gynecol Obstet. 2017;136(2):138–144.
   PubMed Web of Science ®Google Scholar
• Maged AM, Hashem AMT, Gad Allah SH, et al. The effect of loading dose of magnesium sulfate on uterine, umbilical, and fetal middle cerebral arteries Doppler in women with severe preeclampsia: a case control study. Hypertens Pregnancy. 2016;35(1):91–99.
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynaecologists. The management of severe pre-eclampsia. RCOG Guideline 10A;2006.
   Google Scholar
• Andersgaard AB, Herbst A, Johansen M, et al. Eclampsia in Scandinavia: incidence, substandard care, and potentially preventable cases. Acta Obstet Gynecol. 2006;85(8):929–936.
   PubMed Web of Science ®Google Scholar
• Zwart JJ, Richters A, Öry F, et al. Eclampsia in the Netherlands. Obstet Gynecol. 2008;112(4):820–827.
   PubMed Web of Science ®Google Scholar
• Martin JN Jr., Brewer JM, Wallace K, et al. HELLP syndrome and composite major maternal morbidity: importance of Mississippi classification System. J Matern Fetal Neonatal Med. 2013;26(12):1201–1206.
   PubMed Web of Science ®Google Scholar
• Haddad B, Barton JR, Livingston JC, et al. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol. 2000;183(2):444–448.
   PubMed Web of Science ®Google Scholar
• Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074.
   PubMed Web of Science ®Google Scholar
• Abalos E, Cuesta C, Carroli G, et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl 1):14–24.
   PubMed Web of Science ®Google Scholar
• Berg CJ, Harper MA, Atkinson SM, et al. Preventability of pregnancy-related deaths: results of a state-wide review. Obstet Gynecol. 2005;106(6):1228–1234.
   PubMed Web of Science ®Google Scholar
• Roman A. Hypertensive disorders. In: Berghella V, editor. Maternal fetal evidence based guidelines. 3rd ed. Boca Raton (FL): CRC Press; 2017. p. 1–23. Ch 1 P.
   Google Scholar
• Publications Committee, Society for Maternal-Fetal Medicine, Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks’ gestation. Am J Obstet Gynecol. 2011;205(3):191–198.
   PubMed Web of Science ®Google Scholar
• Dekker G. James D, Steer P, Weiner CP, et al., editors. Hypertension. In high risk pregnancy: management options. 4th ed. St. Louis (MO): Elsevier Saunders; 2011. p. 599–626. Chapter 35.
   Google Scholar
• Reimer T, Rohrmann H, Stubert J, et al. Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis. J Matern Fetal Neonatal Med. 2013;26(3):263–269.
   PubMed Web of Science ®Google Scholar
• Kozic JR, Benton SJ, Hutcheon JA, et al. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Can. 2011;33(10):995–1004.
   PubMedGoogle Scholar
• Martin JN Jr., Owens MY, Keiser SD, et al. Standardized Mississippi protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hypertens Pregnancy. 2012;31(1):79–90.
   PubMed Web of Science ®Google Scholar
• Keiser S, Owens M, Parrish M, et al. HELLP syndrome II. Concurrent eclampsia in 70 cases. Abstract No 781. Presented at the 29th Annual Meeting of the Society for Maternal-Fetal Medicine, Jan 26–31, 2009.
   Google Scholar
• Sep SJS, Smits LJM, Prins MH, et al. Simple prepregnant prediction rule for recurrent early-onset hypertensive disease in pregnancy. Reprod Sci. 2009;16(1):80–87.
   PubMed Web of Science ®Google Scholar
• Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio Ipertensione in Gravidanza. Br J Obstet Gynaecol. 1998;105(7):718–722.
   PubMedGoogle Scholar
• O’Brien JM, Barton JR. Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol. 2005 Jun;48(2):460–477.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103(5 Pt 1):981–991.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol. 2013;121(5):1122–1133.
   Google Scholar
• Heinonen S, Tyrväinen E, Saarikoski S, et al. Need for maternal critical care in obstetrics: a population-based analysis. Int J Obstet Anesth. 2002;11(4):260–264.
   PubMed Web of Science ®Google Scholar
• Muench MV, Baschat AA, Malinow AM, et al. Analysis of disease in the obstetric intensive care unit at a university referral center: a 24-month review of prospective data. J Reprod Med. 2008;53(12):914–920.
   PubMed Web of Science ®Google Scholar